Truist Financial analyst David S Macdonald maintained a Buy rating on Option Care Health (OPCH – Research Report) today. The company’s shares closed yesterday at $31.80.
S Macdonald covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, Cigna, and DaVita. According to TipRanks, S Macdonald has an average return of 13.0% and a 67.85% success rate on recommended stocks.
Currently, the analyst consensus on Option Care Health is a Strong Buy with an average price target of $39.67, which is a 24.75% upside from current levels. In a report released on March 4, Jefferies also maintained a Buy rating on the stock with a $38.00 price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $35.74 and a one-year low of $24.23. Currently, Option Care Health has an average volume of 1.28M.
Based on the recent corporate insider activity of 39 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Option Care Health (OPCH) Company Description:
Option Care Health, Inc. provides home and alternate site infusion services. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Read More on OPCH:
- Option Care Health Navigates Vendor Cybersecurity Disruption
- Option Care Health price target raised to $38 from $35 at Barrington
- Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023
- Option Care Health sees FY24 revenue $4.6B-$4.8B, consensus $4.63B
- Option Care Health reports Q4 EPS 32c, consensus 29c
